Background Intake of an edible blue-green alga Nostoc commune var. sphaeroides Kützing (N. commune) has been shown to lower plasma total cholesterol concentration, but the mechanisms behind the hypocholesterolemic effect have not been elucidated. Aim of the study To elucidate the mechanisms underlying the cholesterol-lowering effect of N. commune in mice. Methods Male C57BL/6J mice were fed the AIN-93 M diet supplemented with 0 or 5% (wt/wt) dried N. commune for 4 weeks. Lipid levels in the plasma and liver, intestinal cholesterol absorption, and fecal sterol excretion were measured. Expression of hepatic and intestinal genes involved in cholesterol metabolism was evaluated by quantitative realtime PCR. Results N. commune supplementation significantly reduced total plasma cholesterol and triglyceride concentrations by ~20% compared to controls. Intestinal cholesterol absorption was significantly decreased, while fecal neutral sterol output was significantly increased in N. commune-fed mice. mRNA levels of the cholesterol transporters such as Niemann Pick C1 Like 1, scavenger receptor class B type 1, ATP-binding cassette transporters G5 and A1 in small intestine were not significantly different between two groups. Hepatic lipid contents including total cholesterol, triglyceride and free cholesterol in N. commune-fed mice were not significantly altered. However, the expression of cholesterol-modulating genes including sterol regulatory element binding protein-2 and 3-hydroxy-3-methylglutaryl coenzyme A reductase were significantly increased in
Introduction
Of all cardiovascular diseases, coronary heart disease (CHD) is the leading cause of death for both men and women worldwide. In particular, a positive correlation between death from CHD and total plasma cholesterol (TPC) level exceeding 200 mg/dl prompted the National Cholesterol Education Program (NCEP) to recommend TPC level to remain at 200 mg/dl or lower for the general population [1] . Statin drugs are widely prescribed to lower TPC concentration. However, they can cause adverse effects such as liver dysfunction or myalgia [17, 27] . Lowering TPC through non-drug strategies, such as consuming foods containing bioactive compounds with hypocholesterolemic effects, would therefore be a desirable alternative. Many herbal and functional food supplements have been used for primary prevention of CHD. Soluble fibers from barley, beans, oat bran, and psyllium reduced TPC concentration when consumed by healthy hyperlipidemic patients on a lowfat diet [21] .
Recently, hypocholesterolemic and hypotriglyceridemic properties have been reported with intake of several strains of blue-green algae [20, 24, 36, 38] . Edible blue-green algae, such as Spirulina platensis and Aphanizomenon flosaquae, are currently marketed as dietary supplements with various health claims for immune function, inflammation, and heart disease. Spirulina platensis is harvested from controlled ponds around the world. In contrast, most of Aphanizomenon flosaquae products are harvested from the Upper Klamath Lake in southern Oregon in the United States, where it grows naturally. However, concerns over naturally grown blue-green algae have been raised because they are easily contaminated with hepatotoxin-producing Microcystis aeruginosa as well as with heavy metals [14] .
Nostoc commune var. sphaeroides Kützing (N. commune), an edible blue-green alga, is a cyanobacterium that has been grown and cultivated for medicinal uses for centuries. N. commune is the only edible species of Nostoc listed in the Compendium of Materia Medica, a Chinese medicinal work from 1596. N. commune is currently consumed where it is grown naturally in spherical macrocolonies in both terrestrial and aquatic habitats. It has been historically suggested that N. commune can treat a variety of medical conditions, including inflammation, night blindness, burns, anxiety, and chronic fatigue. Recent research has indicated that N. commune contains cryptophycin, a compound that inhibits cancer cell growth [41] , as well as antiviral compounds [12, 23] . A cholesterol-lowering effect of N. commune was reported in rats fed a high-cholesterol diet, the effects being attributed to its high fiber content [20] . Although studies have shown N. commune to confer health benefits, the investigation into the mechanisms behind the biological effects have been limited. We have previously shown that the lipid extract from N. commune exhibits potential cholesterollowering properties due to its inhibitory effects on the maturation of sterol regulatory element binding protein-2 (SREBP-2) and subsequent reduction of cholesterol synthesis in HepG2 cells, a human hepatoma cell line [33] . The purposes of this study were to determine a hypocholesterolemic effect of cultivated N. commune in vivo and to elucidate a mechanism for such an effect. We show here that consumption of N. commune lowered TPC concentration by reducing intestinal cholesterol absorption.
Materials and methods

Animal feeding and care
Twenty-four C57BL/6J adult male mice (Jackson Laboratory) ranging in age from 11 to 24 weeks were randomly assigned to control or N. commune supplement group and housed individually in a polycarbonate cage under a 12-h light/dark cycle. Initial body weight of mice were not significantly different between two groups (control, 27.9 g; N. commune, 27.8 g; P = 0.96). Fresh N. commune obtained from Algaen Corporation (Winston-Salem, North Carolina, USA) was lypholyzed and stored at -80°C until it was finely ground and incorporated with the remaining diet ingredients. AIN-93 M diet [34, 35] was supplemented with 5% dried N. commune (wt/wt) at the expense of casein, cornstarch, and fiber on the basis of chemical composition of the alga (55.2% protein, 30% carbohydrate except fiber, 8.5% fiber, 6% fat) as determined by Southern Testing and Research Laboratories (Wilson, North Carolina, USA; Table 1 ). Mice were fed an AIN-93 M control diet or N. commune supplemented diet for the 4-week experimental period with free access to food and water. Body weight and food intake were recorded weekly. At the end of the 4 weeks, mice were fasted for 4 h, anesthetized with ketamine HCl (50 mg/kg)/xylazine (10 mg/kg) and subsequently euthanized by cardiac puncture and cervical dislocation. Blood sample collected by cardiac puncture was put into a 2 ml tube containing 3.6 mg EDTA (BD Vacutainer). Blood was centrifuged for 20 min at 5,000 × g at 4°C to remove red blood cells, and plasma was stored at -80°C. Liver and intestine were immediately frozen in liquid nitrogen and stored at -80°C. All procedures were approved by the Institutional Animal Care and Use Committee of the University of Nebraska-Lincoln. 
Plasma and liver lipids
Lipid from liver samples was extracted using the method of Folch et al. [13] and solubilized in Triton X-100 as previously described [6] . Liver and plasma lipids were determined using reagents for total cholesterol (Roche Diagnostics), triglycerides (Roche Diagnostics), free cholesterol (Free Cholesterol E, Wako Chemicals), and phospholipid (Phospholipid C, Wako chemicals) by enzymatic analysis [5] . Liver esterified cholesterol was calculated as the difference between total and free cholesterol.
Gene expression analysis
Approximately 1.0 g of liver or proximal intestinal sample was homogenized (Tissue Tearor, Biospec Products) in 1 ml of TRIzol reagent (Invitrogen) for total RNA isolation following manufacturer's protocol. Reverse transcription for cDNA synthesis and quantitative realtime PCR analysis were performed as previously described [32, 33] . Primers were designed according to GenBank database using the Primer Express software (Applied Biosystems). The following primers were used for realtime PCR analysis: 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR), forward (5′-CCCAGTTGTGCGTCTT CCA-3′), reverse (5′-TTCGAGCCAGGCTTTCACTT-3′); low-density lipoprotein receptor (LDLR), forward (5′-ACTGGGTTGACTCCAAACTTCAC-3′), reverse (5′-GGTTGCCCCCG TTGACA-3′); fatty acid synthase (FAS), forward (5′-CGCTCGGCATGGCTATCT-3′), reverse (5′-CTCGTTGAAGAACGCATCCA-3′); cholesterol 7α hydroxylase (CYP7A1), forward (5′-AGCAACTAAACAACCTGCCAGTACTA-3′), reverse (5′-GTCCGGATATTCAAG GATGCA-3′); sterol regulatory element binding protein 2 (SREBP-2), forward (5′-TCCGCC TGTTCCGATGTAC-3′), reverse (5′-TGCACATTCAGCCAGGTTCA-3′); scavenger receptor class B type 1 (SR-B1), forward (5′-GATGTGGGCACCCTTCATG-3′), reverse (5′-CCG GGCTGAAGAATTCCA-3′); Niemann Pick C1 Like 1 (NPC1L1), forward (5′-CGTCTG TCCCCGCCTATACA-3′), reverse (5′-CTAATGACACCAGCTGCTTGGT-3′); ATP-binding cassette transporter A1 (ABCA1), forward (5′-CGTTTCCGGGAAGTGTCCTA-3′), reverse (5′-GCTAGAGATGACAAGGAGGATGGA-3′); ATP binding cassette transporter G5 (ABCG5), forward (5′-CGTGGCGGACCAAATGA-3′), reverse (5′-GCTCGCCACTGGAAATTCC-3′); glyceraldehyde 3-phosphate dehydrogenase (GAPDH), forward (5′-GTGGTCTCCTCT GACTTCAACA-3′), reverse (5′-GTTGCTGTAGCCAAATTCGTTGT-3′).
Cholesterol absorption efficiency
Fractional intestinal cholesterol absorption was measured using dual-isotope method [3] .
In brief, at week 3, mice were orally administered 17 μl of [ 3 H]-β-sitostanol and [ 14 C]-cholesterol (American Radiolabeled Chemicals) mixture in soybean oil for two consecutive days for an intake of 100,000 dpm of [ 3 H]-β-sitostanol and [ 14 C]-cholesterol each day. As our previous studies have shown that the majority of radiolabeled cholesterol is excreted at days 5-7, bedding and feces were collected at those days for analysis. Fecal sterol was extracted as previously described [39] and radioactivity was counted using a liquid scintillation counter (Packard). Cholesterol absorption efficiency was calculated as a % from the ratio of the two radiolabels in the dose and feces using the following equation: Percentage cholesterol absorption = [( 14 C/ 3 H in dose-14 C/ 3 H in feces)/( 14 C/ 3 H in dose)] × 100.
Fecal sterols
Fecal neutral and plant sterols were determined by gas chromatography, and acidic sterols were determined by enzymatic analysis using Wako Bile Acid Kit (Wako Chemicals). The procedures were previously described [39] .
Statistical analysis
Unpaired T-test was used to identify statistically significant differences between two groups with P < 0.05 considered significant by GraphPad InStat 3 (GraphPad Software, Inc.). Data are expressed as mean ± SEM.
Results
Safety of N. commune consumption
Plasma levels of clinical indicators for tissue damage such as ALT, AST, and BUN were measured to determine the safety of N. commune consumption. ALT is often used as an indicator of liver damage, and AST, while it is also indicative of liver damage, is used to assess damage to other body organs. BUN is a byproduct of protein catabolism and is an indicator of kidney function. Plasma concentrations of AST, ALT, and BUN in N. communefed mice were not significantly different from those of control group (data not shown). No significant differences in food intake between two groups were seen throughout the 4-week experiment (control, 4.2 g/day; N. commune, 4.0 g/ day; P > 0.05). Body weights of mice fed control or N. commune supplemented diet were not significantly different after 4-week dietary treatment (control, 30.3 g; N. commune, 29.2 g; P = 0.38). The data suggest that mice consuming 5% N. commune supplementation were healthy without manifesting signs of toxicity from algal supplementation when they were on N. commune supplemented diet for a month.
Effect of N. commune supplementation on plasma and liver lipids Five percent N. commune supplementation for 4 weeks significantly decreased plasma concentrations of total cholesterol and triglycerides as compared to the control group (Fig. 1) . Despite the reduction of plasma lipid concentrations, no significant differences were seen in hepatic total cholesterol, triglyceride and phospholipid between the two groups ( Table 2) . Free and esterified cholesterol contents in the liver were not different in control and N. commune-fed mice (data not shown). Values represent mean ± SEM (n = 12) * Significantly different from control (P < 0.05)
Alteration in hepatic gene expression by N. commune supplementation
To evaluate whether N. commune supplementation altered the expression of genes involved in cholesterol metabolism and transport in the liver, realtime PCR analysis was conducted utilizing GAPDH as a reference gene. A significant increase in mRNA abundance of both SREBP-2 and HMGR was observed with N. commune supplementation compared with control animals (Fig. 2) . While LDLR mRNA was not significantly increased, a trend toward increase was seen in the N. commune-fed group (P = 0.098). In addition, a trend toward decrease in FAS (P = 0.061) was seen in mice fed N. commune. CYP7A1, the rate-limiting enzyme for bile acid biosynthesis, mRNA levels were significantly increased (P = 0.004) in N. commune-fed mice but its protein levels were not altered (data not shown). Inhibition of cholesterol absorption by N. commune Cholesterol absorption plays a major role in the regulation of whole body cholesterol homeostasis [16, 45] . To determine if the hypocholesterolemic effect of N. commune is at least partly attributed to altered intestinal cholesterol absorption, cholesterol absorption efficiency was assessed by a fecal dual-isotope ratio method. Cholesterol absorption efficiency in control mice was 80% while N. commune-fed mice exhibited a significant reduction at 68% (Table 3) , possibly accounting for the reduction in TPC concentration seen in these mice. The expression of the intestinal transporters known to be involved in cholesterol absorption such as NPC1L1, SR-BI, ABCG5, and ABCA1 were not significantly different between two groups (data not shown) [2, 19, 42] . Values represent mean ± SEM (n = 8 for control, 9 for N. commune) * Significantly different from control (P < 0.05)
Increased sterol excretion by N. commune supplementation Fecal sterol output was determined to investigate if N. commune supplementation could alter excretion of cholesterol and bile acid. As expected based on reduced cholesterol absorption in N. commune-fed mice, cholesterol output was increased more than two-fold with N. commune supplementation compared with controls (Table 3) . Plant sterols including campesterol, sitosterol, and stigmasterol were excreted significantly more in N. commune-fed mice than controls. In contrast, output of acidic sterols, consisting of both bile acids and bile salts, remained unchanged between groups. Fecal output weight was also significantly increased in N. commune-fed mice (data not shown).
Discussion
Consumption of foods containing bioactive compounds as an alternative or a supplement to prescription drugs is gaining in popularity. In this study, we sought to unveil mechanisms for the cholesterol-lowering effects of N. commune. It was shown that intake of N. commune in rats reduced TPC concentration, which was attributed to the fiber component of the N. commune [20] . However, as N. commune used in that study was naturally grown, the macronutrient distribution would be unique to that harvest and would not be equated to the cultivated N. commune utilized in our study. Our results demonstrate that N. commune, at 5% of the diet by weight, reduces TPC concentration by reducing intestinal cholesterol absorption, providing a mechanism for the cholesterol-lowering effect in N. commune-fed mice.
Intestinal cholesterol absorption is primarily protein-mediated. Several transporters have been suggested to directly or indirectly affect intestinal cholesterol absorption, including NPC1L1, SR-BI, ABCA1, and ABCG5/G8. In particular, recent studies suggest a critical role of NPC1L1 in cholesterol and plant sterol absorption [2, 7, 37] . To determine if the reduction in cholesterol absorption by N. commune was due to a direct effect on these transporters, we measured mRNA abundance of intestinal cholesterol transporters such as NPC1L1, SR-B1, ABCG5, and ABCA1. There were no significant differences in the expression of the genes between control and N. commune-fed mice. Although we cannot rule out a possibility for the post-transcriptional regulation of the gene expression, the result suggests that the reduced cholesterol absorption by N. commune appears to be attributed to its effect within the intestinal lumen without a direct effect on the expression of the cholesterol transporter genes.
If cholesterol transporters do not directly play a role in the alteration of cholesterol absorption in N. commune-fed mice, an effect within the intestinal lumen may be occurring. Various dietary components have the capability to decrease cholesterol absorption including plant sterols [28, 31] and soluble fiber [22, 43] . Soluble polysaccharide from red microalga Porphyridium sp. and its biomass reduced serum cholesterol level in rats [10] . Even though the exact polysaccharide composition of N. commune is not known, compositional analysis of N. commune used in the current study revealed that it contained ~9% fiber. A significant increase in fecal output mass in N. commune-fed mice (data not shown) further supports a potential role of N. commune fiber in modulating the environment of the intestinal lumen. Additionally, GC analysis revealed that dry N. commune contains 3.25 μg/g of sitosterol with no detectible amount of cholesterol. Therefore, we speculate the fiber and plant sterol in N. commune are responsible, at least in part, for the diminished intestinal cholesterol absorption. In addition to fiber and plant sterols, protein from plant sources may affect cholesterol absorption. C-phycocyanin, a phycobiliprotein in Spirulina plantensis with high levels of cystine, possesses hypocholesterolemic properties by reducing micellar solubility of cholesterol and cholesterol absorption, consequently increasing fecal neutral and acidic sterol output [29] . As N. commune is known to contain C-phycocyanin [15] , it is possible that C-phycocyanin might contribute to the inhibition of cholesterol absorption by N. commune. In addition, the lipid fraction of N. commune equals ~6% of the dry weight.
Analysis by thin-layer chromatography and gas chromatography showed that approximately 15% of the lipid fraction consists of fatty acids, 75% of which are unsaturated fatty acids [32] . While these fatty acids may have potential anti-inflammatory properties, their low amount in the diet is unlikely to affect plasma cholesterol levels.
Hepatic cholesterol synthesis is sensitive to the quantity of cholesterol that reaches the liver from the intestine via the chylomicron-remnant pathway [8] . While no significant changes in liver lipids were observed with N. commune supplementation, liver weights were significantly reduced in N. commune-fed mice, and a trend toward a decrease in hepatic lipid content was seen. Gene expression analysis by realtime PCR indicated a significant increase in several cholesterol-modulating genes, including SREBP-2 and HMGR. When cellular cholesterol is depleted, SREBP-2 is activated to increase the transcription of genes involved in cholesterol biosynthetic pathway and uptake, including HMGR, LDLR, HMG-CoA synthase, farnesyl diphosphate synthase and squalene synthase [11, 18, 30] . The increase in SREBP-2 and subsequently HMGR expression observed with N. commune supplementation could have been the result of minor but sufficient enough changes in hepatic cholesterol status to upregulate cholesterol synthesis for maintaining cholesterol homeostasis. Additionally, we cannot rule out the possibility that free cholesterol content in subcellular compartments such as endoplasmic reticulum membrane, where SREBP-2 and HMGR reside, could be altered by N. commune without a change in total free cholesterol contents.
LDLR is responsible for the uptake of LDL from circulation, and increased LDLR is associated with decreased plasma LDL cholesterol concentration [4] . Although it did not reach a statistical significance, N. commune-fed mice exhibited a slight increase in LDLR mRNA, which could contribute to the reduced TPC concentration. The decrease in TPC levels in N. commune-fed mice might also be due to its effect on a different aspect of lipoprotein metabolism such as very low density lipoprotein (VLDL) metabolism. Fatty acid and triglyceride synthesis in the liver regulate the assembly and secretion of VLDL [9, 44] . Enzymes involved in fatty-acid synthesis and uptake, such as acetyl-CoA carboxylase, FAS, and stearoyl CoA desaturase, are under the transcriptional regulation of SREBP-1c [25, 26, 40] . FAS expression in N. commune-fed animals showed a trend toward decrease (P = 0.062). Potential inhibition of lipogenesis by N. commune may decrease VLDL formation, which could reduce plasma concentrations of total cholesterol and triglyceride as seen in N. commune-fed animals.
Inflammation and dyslipidemia are two major contributing factors involved in the progression of atherosclerosis. Lifestyle factors, including diet, influence atherosclerosis development which leads to CHD as a significant cause of death worldwide. While drugs are commonly used to control dyslipidemia such as high plasma cholesterol and triglyceride levels, consumption of natural products for dietary regulation of plasma lipids are becoming increasingly popular. Our previous research has shown N. commune lipid extract to have an anti-inflammatory effect in RAW 264.7 macrophages [32] , as well as an inhibitory role in SREBP-1 and 2 maturation [33] , indicating a potential athero-protective role of N. commune. Additionally, our current study indicates that whole N. commune supplementation decreases the absorption of cholesterol within the intestinal lumen, reducing TPC concen-tration. The combination of these beneficial effects of N. commune intake on lipid metabolism may provide a beneficial alternative for lowering plasma cholesterol concentration in the human population.
